USD 12.46
(-10.1%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -1.85 Million USD | 4.43% |
2022 | -1.94 Million USD | -513.92% |
2021 | -316 Thousand USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -524 Thousand USD | -0.58% |
2024 Q1 | -521 Thousand USD | -117.81% |
2023 FY | -1.85 Million USD | 4.43% |
2023 Q4 | 2.92 Million USD | 754.36% |
2023 Q3 | -447 Thousand USD | 30.27% |
2023 Q1 | -637 Thousand USD | -7.06% |
2023 Q2 | -641 Thousand USD | -0.63% |
2022 Q3 | -539 Thousand USD | -189.78% |
2022 Q4 | -595 Thousand USD | -10.39% |
2022 FY | -1.94 Million USD | -513.92% |
2022 Q2 | -186 Thousand USD | -0.54% |
2022 Q1 | -185 Thousand USD | -46.83% |
2021 Q1 | - USD | 0.0% |
2021 FY | -316 Thousand USD | 0.0% |
2021 Q4 | -126 Thousand USD | -50.0% |
2021 Q3 | -84 Thousand USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Abbott Laboratories | 22.13 Billion USD | 100.008% |
Allurion Technologies Inc. | 41.49 Million USD | 104.468% |
Artivion, Inc. | 229.17 Million USD | 100.809% |
Avanos Medical, Inc. | 379.7 Million USD | 100.488% |
Butterfly Network, Inc. | 16.85 Million USD | 110.999% |
Butterfly Network, Inc. | 16.85 Million USD | 110.999% |
Bio-Rad Laboratories, Inc. | 1.43 Billion USD | 100.13% |
Boston Scientific Corporation | 9.89 Billion USD | 100.019% |
Perspective Therapeutics, Inc. | 1.63 Million USD | 213.464% |
CONMED Corporation | 643.06 Million USD | 100.288% |
Edwards Lifesciences Corporation | 4.62 Billion USD | 100.04% |
Paragon 28, Inc. | 172.79 Million USD | 101.073% |
Glaukos Corporation | 239.13 Million USD | 100.775% |
Globus Medical, Inc. | 1.02 Billion USD | 100.182% |
Inspire Medical Systems, Inc. | 528.22 Million USD | 100.351% |
Integer Holdings Corporation | 418.28 Million USD | 100.443% |
Medtronic plc | 19.45 Billion USD | 100.01% |
Nevro Corp. | 290.06 Million USD | 100.639% |
Owlet, Inc. | 22.58 Million USD | 108.208% |
Penumbra, Inc. | 682.64 Million USD | 100.272% |
Smith & Nephew plc | 3.7 Billion USD | 100.05% |
Sonendo, Inc. | 10.72 Million USD | 117.292% |
STERIS plc | 2.23 Billion USD | 100.083% |
Stryker Corporation | 13.05 Billion USD | 100.014% |
Vapotherm, Inc. | 28.28 Million USD | 106.555% |
Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 100.035% |